Latest Asx Results News

Page 8 of 10
EVT delivered growth across hotels, cinemas and Thredbo in FY2026 while outlining an approximately $500 million non-core property divestment programme. The group is also reviewing its structure as it redirects capital towards asset-light hotel expansion and considers potential special dividends.
Victor Sage
Victor Sage
21 Sept 2026
Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.
Victor Sage
Victor Sage
21 Sept 2026
Globe International increased FY2026 EBIT and net profit despite almost no revenue growth, as a tighter brand portfolio improved margins across all three regions. The ASX-listed group also lifted its fully franked annual dividend to 23 cents per share and ended the year with A$26.7 million in cash.
Victor Sage
Victor Sage
18 Sept 2026
MyState delivered a sharp rise in FY26 profit as Auswide integration produced $11.8 million in run-rate synergies, while the group lifted its full-year dividend to 24.5 cents per share. The next test is turning early integration gains into a larger payoff without losing control of technology costs and credit risk.
Claire Turing
Claire Turing
18 Sept 2026
Otto Energy delivered a sharp rise in FY26 profit and operating cash flow, but the improvement came alongside falling production, depleted reserves and an unresolved asset monetisation plan. The debt-free oil and gas producer is now weighing a shareholder cash return while pursuing separate strategies for SM 71 and GC 21.
Victor Sage
Victor Sage
18 Sept 2026
Acumentis delivered a sharp improvement in profit and cash generation despite lower revenue, supported by cost control and diversification beyond mortgage valuations. The result comes with a governance complication: a Section 249D requisition seeking to replace the chairman and managing director.
Victor Sage
Victor Sage
18 Sept 2026
Argo Investments delivered an 8.7% portfolio return and record fully franked dividends in FY2026, while flagging a shift to quarterly distributions from January. The listed investment company intends to pay 40 cents per share across its first four quarterly dividends, subject to Board declarations.
Claire Turing
Claire Turing
18 Sept 2026
Austco Healthcare delivered record FY26 revenue and statutory profit, with stronger margins, cash generation and a modest recovery in contracted orders entering the new financial year. The company is pairing that momentum with further reseller consolidation, including the $2.88 million acquisition of Medical Communications Systems.
Victor Sage
Victor Sage
17 Sept 2026
Codan Limited (ASX:CDA) has entered FY27 with record revenue, profit and a sharply larger Communications orderbook, while targeting approximately 20% Communications revenue growth. The forecast is conditional on supply-chain capacity as demand for unmanned systems and new gold detectors accelerates.
Sophie Babbage
Sophie Babbage
17 Sept 2026
Data#3 delivered another record year, lifting gross sales 12.7% to $3.4 billion and profit before tax 14% to $78.8 million. The result came with a higher dividend and stronger recurring sales, but weaker Services performance, lower margins and softer operating cash flow leave FY27 with a clear execution challenge.
Victor Sage
Victor Sage
17 Sept 2026
Eneco Refresh has delivered its strongest profit in five years despite raw material inflation and logistics disruption, with operating cash flow and cash reserves also improving. The company now has scope to invest in automation and consider selective acquisitions, but offers no FY2027 earnings guidance or dividend.
Victor Sage
Victor Sage
16 Sept 2026
PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.
Victor Sage
Victor Sage
15 Sept 2026

Browse the archive

Full archive